Skip to Content
Merck
All Photos(2)

Key Documents

More Documents

Safety Information

P2B010A01

Millipore

Pellicon® 2 Mini Ultrafiltration Biomax® Module

filtration area 0.1 m2, NMWCO 10 kDa

Synonym(s):

Pellicon® 2 Mini Ultrafiltration Module Biomax-10 A 0.1 m2

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

UNSPSC Code:
23151806

material

polyethersulfone
polypropylene screen
polyurethane adhesive

Quality Level

400

manufacturer/tradename

Pellicon®

parameter

0.33 bar max. transmembrane pressure (5 psig) (reverse)
4-6 L/min recirculation rate at 1.4 bar (20 psi)
7 bar max. transmembrane pressure (100 psig) at 30 °C (forward)

technique(s)

analytical sample preparation: suitable
protein purification: suitable

H

1.5 cm (0.6 in.)

L

21 cm (8.3 in.)

W

5.6 cm (2.2 in.)

filtration area

0.1 m2

membrane nominal area

0.1 m2

gravimetric extractables

≤1500 mg/m2

matrix

Biomax®

pore size

10 kDa NMWCO

pH

1-14

Looking for similar products? Visit Product Comparison Guide

General description

The Pellicon® 2 Ultrafiltration BIOMAX 10 Mini Cassette sets the standard in cassette-style tangential flow filtration devices. P2B010A01 was designed with process scale-up and applications development in mind.

Millipore′s BIOMAX 10 polyethersulfone membrane has void-free structures that guard against leakage of solutes through microdefects normally associated with voids beneath the thin skins of conventional UF membranes. These void-free membranes are more permeable, resulting in high-flux with equivalent or superior product retention. These void-free membranes provide the advantages of fast, high yield processing and smaller systems.

The Pellicon® 2 Mini Ultrafiltration BIOMAX Module feature a filtration area of 0.1 m2 with a pore size of 10 kDa NMWCO.

Application

Concentration, desalting or buffer exchange of:
  • Protein solutions
  • Polysaccharide solutions
  • Virus suspensions


Harvest, washing or clarification of:
  • Cell cultures and lysates
  • Colloidal suspensions
  • Viral cultures

Features and Benefits

  • Type A screen (tight screen)
  • Leading-edge void- free membranes to match virtually any separation challenge
  • Short flow path for higher flux and higher resolution separation capability
  • Choice of flow channel configuration providing process optimization capability
  • Predictable, fast, scale-up
  • True linear scalability from laboratory size modules to industrial assemblies for processing thousands of liters
  • Brings higher resolution, improved yields and superior back-pressure resistance
  • Ultracel membranes are composite membranes cast on a microporous substrate for defect-free membranes with superior

Other Notes

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.
Prefiltration Rquirements: 100 µm

Analysis Note

Gravimetric Extractables: after a water flush

Legal Information

BIOMAX is a registered trademark of Merck KGaA, Darmstadt, Germany
Pellicon is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

ISHL Notified Names

Substances Subject to be Notified Names

JAN Code

P2B010A01:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Su Jeen Lee et al.
Immunity, inflammation and disease, 8(2), 216-227 (2020-03-14)
Varicella-zoster virus (VZV), a human alphaherpesvirus 3, elicits both chickenpox and shingles and/or postherpetic neuralgia. A live attenuated vaccine (LAV) and glycoprotein E (gE) subunit vaccine were developed to prevent VZV-induced diseases. We recently reported that single-strand RNA (ssRNA) based

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service